
Quest Introduces Myeloma Test That Eliminates the Need for Bone Marrow Biopsies
The flow cytometry assay costs a fraction of traditional invasive bone marrow testing

The flow cytometry assay costs a fraction of traditional invasive bone marrow testing

The test offers a 76 percent sensitivity to detection of stage 1 and stage 2 pancreatic cancers

A physics-based urine test shows early promise in detecting bladder cancer recurrence without invasive procedures

The skin-based test can be used on children as young as two days old

TruVerus is designed to perform a slew of clinical laboratory tests on as few as eight drops of blood